Jonathan Schott
Jonathan Schott is the chief medical officer at Alzheimer’s Research UK and a neurology professor at University College London. He co-authored critiques on the definitions of Alzheimer’s disease, stressing that current biomarker-positive tests should be viewed as indicators of risk rather than definitive diagnoses, as research continues to evolve in this field.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 5.00 | 0.03% | +0% | 67,886,011 | 18,293 | $2,700,000 | 728$ |
| Totals | 1 | 67,886,011 | 18,293 | $2,700,000 | 728$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Jonathan Schott emphasizes that biomarker-positive tests should indicate risk rather than proof of disease.
5